サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1606510

ハンドヘルド低侵襲手術器具の世界市場-2024～2031年

Global Handheld Minimally Invasive Surgical Instruments Market - 2024-2031

出版日
ページ情報
英文 197 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ハンドヘルド低侵襲手術器具の世界市場-2024～2031年
出版日: 2024年12月04日
発行: DataM Intelligence
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

ハンドヘルド低侵襲手術器具の世界市場は、2023年に70億9,000万米ドルに達し、2031年には156億4,000万米ドルに達すると予測され、予測期間2024～2031年のCAGRは10.4%で成長する見込みです。

ハンドヘルド低侵襲手術器具は、低侵襲外科手術に使用するために設計された手術器具のカテゴリーを指します。これらの器具は、周囲の組織への外傷を最小限に抑えながら、正確で制御された効率的な手術を行うために特別に設計されており、患者の回復時間の短縮、感染リスクの低減、傷跡の軽減につながります。これらの器具は一般的に、従来の手術器具よりも小さく、軽く、人間工学的に設計されています。そのコンパクトなサイズにより、周囲の組織に大きなダメージを与えることなく、数ミリ程度の小さな切開創にフィットさせることができます。

ハンドヘルド低侵襲手術器具市場は、手術技術の進歩、低侵襲手術への嗜好の高まり、患者中心の医療によって力強い成長を遂げています。手術件数の増加に伴い、これらの器具の需要は世界的に増加し続けると予想されます。例えば、サスカチュワン州政府によると、2023年4月1日から2024年3月31日の間に9万5,700件以上の手術が行われ、年間手術件数としては過去最高を記録しました。

市場力学：

促進要因と抑制要因

低侵襲手術に対する需要の増加

低侵襲手術に対する需要の増加は、ハンドヘルド低侵襲手術器具市場の成長を大きく後押ししており、予測期間中も市場を牽引していくとみられます。低侵襲手術は、切開創が小さく、出血量が少なく、回復が早く、合併症が少ないことが特徴で、患者と医療プロバイダーの両方で広く採用されつつあります。このような外科手術の変化により、これらの手術を行う上で重要な役割を果たすハンドヘルド低侵襲手術器具のような高度で精密なツールに対する需要が高まっています。

米国顔面形成外科学会（AAFPRS）によると、2023年に行われた手術の総数の83％が低侵襲手術でした。さらに、カルタヘナで開催されたISAPS世界会議の手技によると、外科手術の増加率は5.5％と高く、形成外科医による手術は1,580万件を超えます。過去4年間で、全体の増加率は40％です。この手術件数の増加と低侵襲手術が、ハンドヘルド低侵襲手術器具の成長を牽引しています。

切開創を小さくすることで、感染、出血、瘢痕のリスクを軽減することができます。これは、術後の合併症を最小限に抑えた手術を好む患者にとって特に魅力的です。例えば、Lancet誌に掲載された研究によると、腹腔鏡手術を受けた患者は、従来の開腹手術を受けた患者に比べて合併症が50%少なかった。

高価な器具と技術

器具や技術のコストが高いことがハンドヘルド低侵襲手術器具市場の成長を大きく妨げており、予測期間中も市場の成長を妨げると予想されます。低侵襲手術は、回復時間の短縮、合併症の減少、患者満足度の向上など数多くの利点をもたらすが、特に低所得地域や予算に制約のある地域の医療システム、病院、患者にとっては、先進的手術器具や技術の関連コストが障壁となる可能性があります。

腹腔鏡ハサミ、内視鏡鉗子、ロボット支援ツールなど、低侵襲手術に使用されるハンドヘルド器具の多くは、高額な初期費用がかかります。これらの器具は、先進的材料、精密工学、特殊な機能を備えていることが多く、これらすべてが高価格の原因となっています。例えば、ScienceDirectによると、一般外科手術におけるハンドヘルド型ロボット器具の直接器具費用は、ハンドXとダヴィンチを比較した場合、それぞれ310ドル対973ドルでした。

ハンドヘルド器具の多くは、リアルタイムの視覚化を提供する腹腔鏡や内視鏡などの画像技術とともに使用されます。これらの技術は外科手術の精度を向上させるが、同時に高いコストを伴います。例えば、高解像度の内視鏡システムは2万5,000ドルから5万ドルであり、3D画像やリアルタイムデータ処理と統合された先進的システムは、コストをさらに押し上げる可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 低侵襲手術の需要増加
      • 外科用器具の技術的進歩
    • 抑制要因
      • 機器と技術の高コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 特許分析
  • 規制分析
  • SWOT分析
  • アンメットニーズ

第6章 製品タイプ別

  • 把持器と鉗子
  • ニードルホルダー
  • メスと解剖器具
  • リトラクター
  • はさみ
  • その他

第7章 用途別

  • 腹腔鏡検査
  • 関節鏡検査
  • 内視鏡検査
  • その他

第8章 エンドユーザー別

  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • 中東・アフリカ

第10章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第11章 企業プロファイル

  • Medtronic plc
  • Olympus Corporation
  • Stryker Corporation
  • Meril Life Sciences Pvt. Ltd.
  • Boston Scientific Corporation
  • Wexler Surgical
  • CONMED Corporation
  • Smith+Nephew
  • CooperSurgical Inc.
  • Johnson & Johnson

第12章 付録

目次
Product Code: MD8805

Overview

The global handheld minimally invasive surgical instruments market reached US$ 7.09 billion in 2023 and is expected to reach US$ 15.64 billion by 2031, growing at a CAGR of 10.4% during the forecast period 2024-2031.

Handheld minimally invasive surgical instruments refer to a category of surgical tools designed for use in minimally invasive surgical procedures, where smaller incisions are made in the body compared to traditional open surgery. These instruments are specifically designed to facilitate precise, controlled and efficient surgery with minimal trauma to surrounding tissues, leading to faster recovery times, reduced risk of infection and less scarring for patients. These instruments are typically smaller, lighter and more ergonomically designed than traditional surgical tools. Their compact size allows them to fit through smaller incisions, often as small as a few millimeters, without causing significant damage to the surrounding tissues.

The handheld minimally invasive surgical instruments market is experiencing robust growth, fueled by advancements in surgical technology, an increasing preference for minimally invasive procedures, and patient-centered care. With the rising number of surgeries, the demand for these instruments is expected to continue to rise globally. For instance, according to the Government of Saskatchewan, more than 95,700 surgeries were performed between April 1, 2023, and March 31, 2024, the highest annual surgical volume ever recorded.

Market Dynamics: Drivers & Restraints

Increasing demand for minimally invasive surgeries

Increasing demand for minimally invasive surgeries is significantly driving the growth of the handheld minimally invasive surgical instruments market and is expected to drive the market over the forecast period. Minimally invasive surgery, characterized by smaller incisions, reduced blood loss, faster recovery and fewer complications, is gaining widespread adoption among both patients and healthcare providers. This shift in surgical practices is increasing the demand for advanced, precision-driven tools such as handheld minimally invasive surgical instruments, which play a critical role in performing these procedures.

According to the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), 83 percent of the total number of procedures performed in 2023 were minimally invasive. Additionally, according to the procedures at the ISAPS World Congress in Cartagena, there is a higher increase of 5.5% in surgical procedures, with more than 15.8 million procedures performed by plastic surgeons. Over the last four years, the overall increase is 40%. This increasing number of surgeries and minimally invasive surgeries driving the growth of handheld minimally invasive surgical instruments.

Smaller incisions reduce the risk of infection, bleeding, and scarring. This is particularly attractive to patients who prefer procedures with minimal post-surgical complications. For instance, a study published in by Lancet found that patients who underwent laparoscopic surgery experienced 50% fewer complications compared to those who had traditional open surgery.

High cost of instruments and technologies

The high cost of instruments and technologies is significantly hampering the growth of the handheld minimally invasive surgical instruments market and is expected to hamper the market growth over the forecast period. While minimally invasive surgeries offer numerous advantages, such as reduced recovery times, fewer complications and enhanced patient satisfaction, the associated costs of advanced surgical tools and technologies can be a barrier, particularly for healthcare systems, hospitals and patients in lower-income regions or those with budget constraints.

Many handheld instruments used in minimally invasive procedures, such as laparoscopic scissors, endoscopic forceps and robotic-assisted tools, come with high upfront costs. These tools often feature advanced materials, precision engineering and specialized functionalities, all of which contribute to their high price. For instance, according to ScienceDirect, direct instrument costs for handheld robotic devices in general surgery were $310 vs $973 when comparing HandX with the DaVinci, respectively.

Many handheld instruments are used alongside imaging technologies, such as laparoscopes and endoscopes which provide real-time visualization. While these technologies improve surgical precision, they also come with high costs. For instance, a high-definition endoscopic system can cost between $25,000 and $50,000, while advanced systems integrated with 3D imaging or real-time data processing can push costs even higher.

Segment Analysis

The global handheld minimally invasive surgical instruments market is segmented based on product type, application, end-user and region.

Application:

The laparoscopy segment is expected to dominate the global handheld minimally invasive surgical instruments market share

The laparoscopy segment holds a major portion of the handheld minimally invasive surgical instruments market share and is expected to continue to hold a significant portion of the market share over the forecast period. This surgical technique, which uses small incisions and specialized tools to perform surgeries, has seen widespread adoption in a variety of medical fields due to its numerous advantages.

For instance, the Lancet study included 97,234 surgical procedures across 676 public hospitals. In total, 16,061 (16.5%) were performed using laparoscopic approaches, which were less common across all procedure categories. The growing preference for laparoscopic surgery is driving the demand for handheld instruments specifically designed for these procedures, which is a major factor contributing to its dominance.

Laparoscopy has become the gold standard for many types of minimally invasive surgeries because it offers faster recovery times, less postoperative pain and smaller scars. These advantages are particularly appealing to patients, leading to the growing preference for laparoscopic techniques. For instance, HandX is a lightweight, FDA-cleared and CE-marked device that combines the benefits of robotics and handheld instruments. HandX allows the surgeon to perform complex minimally invasive surgeries using a device that combines the benefits of a surgical robotic-based platform with the simplicity and affordability of traditional laparoscopic surgery.

Geographical Analysis

North America is expected to hold a significant position in the global handheld minimally invasive surgical instruments market

North America region is expected to hold the largest share in the handheld minimally invasive surgical instruments market over the forecast period. Hospitals and surgical centers in North America, especially in the United States are among the most advanced globally, with a high penetration of minimally invasive surgery tools, including laparoscopic and robotic-assisted instruments.

For instance, in the United States, major hospitals like the Cleveland Clinic and Mayo Clinic are recognized globally for their adoption of robot-assisted and laparoscopic surgeries, which require a wide range of handheld minimally invasive surgical instruments.

Specialized centers for procedures such as cardiac surgery, bariatric surgery, orthopedic surgery and gastrointestinal surgeries often use advanced handheld minimally invasive instruments, further driving demand in the region. A report by IBISWorld indicated that the U.S. healthcare sector was valued at approximately $4.8 trillion in 2023, with a significant portion allocated to surgical services and procedures that use minimally invasive techniques.

Asia Pacific is growing at the fastest pace in the Handheld Minimally Invasive Surgical Instruments market

The Asia Pacific region is experiencing the fastest growth in the handheld minimally invasive surgical instruments market. Many countries in the Asia-Pacific, particularly China, India and Japan, are significantly improving their healthcare infrastructure and investing in modern medical technologies. This is facilitating the adoption of advanced surgical techniques, including minimally invasive surgeries, which require handheld instruments.

As healthcare costs rise and patients seek faster recovery times with fewer complications, there is a strong demand for minimally invasive surgeries in Asia Pacific. Patients in countries like Japan, South Korea and India are increasingly opting for these procedures due to their benefits, such as shorter hospital stays, less postoperative pain and smaller scars. For instance, according to the NIH, more than 570 da Vinci (uses hand-held, long-shafted instruments) units were operational in Japan in 2023, highlighting the growing acceptance of robotic surgery despite the challenges.

Competitive Landscape

The major global players in the handheld minimally invasive surgical instruments market include Medtronic plc, Olympus Corporation, Stryker Corporation, Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, Wexler Surgical, CONMED Corporation, Smith+Nephew, CooperSurgical Inc., Johnson & Johnson and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global handheld minimally invasive surgical instruments market report would provide approximately 62 tables, 57 figures and 197 pages.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Demand for Minimally Invasive Surgeries
      • 4.1.1.2. Technological Advancements in Surgical Tools
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Instruments and Technologies
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis
  • 5.6. SWOT Analysis
  • 5.7. Unmet Needs

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Graspers and Forceps*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Needle Holders
  • 6.4. Scalpels and Dissection Instruments
  • 6.5. Retractors
  • 6.6. Scissors
  • 6.7. Others

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Laparoscopy*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Arthroscopy
  • 7.4. Endoscopy
  • 7.5. Others

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Specialty Clinics
  • 8.5. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Medtronic plc*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Olympus Corporation
  • 11.3. Stryker Corporation
  • 11.4. Meril Life Sciences Pvt. Ltd.
  • 11.5. Boston Scientific Corporation
  • 11.6. Wexler Surgical
  • 11.7. CONMED Corporation
  • 11.8. Smith+Nephew
  • 11.9. CooperSurgical Inc.
  • 11.10. Johnson & Johnson

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us